ヨーロッパの脂質パネル検査市場、製品とサービス別（デバイス、キット、サービス）、処方モード別（処方箋に基づく検査とOTCに基づく検査）、アプリケーション別（高脂血症、高トリグリセリド血症、家族性高コレステロール血症、低リポタンパク血症、タンジール病、アテローム性動脈硬化症など）、エンドユーザー別（病院、専門クリニックと医師のオフィス、病理学研究所、診断クリニック、外来手術センター、リファレンス研究所、学術研究機関など）、流通チャネル別（直接入札、小売薬局、オンライン販売など） - 2030年までの業界動向と予測。
欧州脂質パネル検査市場の分析と洞察
ヨーロッパでは脂質パネル検査に対する意識が高まり、市場の需要が高まっています。より良い医療サービスを求める医療費の増加も、市場の成長に寄与しています。主要な市場プレーヤーは、この重要な時期にさまざまなサービスの立ち上げと承認に注力しています。さらに、プロセスと技術の進歩の向上も、脂質パネル検査の需要増加に寄与しています。
ヨーロッパの脂質パネル検査市場は、市場プレーヤーの増加と高度なサービスの利用可能性により、予測年度に成長すると予想されています。これに伴い、メーカーは市場で新しいサービスと効率的で正確な脂質パネル検査を開始するための開発活動に取り組んでいます。高度なヘルスケア技術の開発の増加は、市場の成長をさらに後押ししています。ただし、脂質パネル検査製品の製造と商品化に関する厳格な規制などの困難が、予測期間中のヨーロッパの脂質パネル検査市場の成長を妨げる可能性があります。
Data Bridge Market Researchは、ヨーロッパの脂質パネル検査市場は予測期間中に6.7%のCAGRで成長し、2030年までに43億7,847万米ドルの価値に達すると予測しています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 (2015～2020年にカスタマイズ可能) |
|
定量単位 |
売上高（百万）、販売数量（個）、価格（米ドル） |
|
対象セグメント |
製品とサービス (デバイス、キット、サービス)、処方モード (処方箋に基づく検査と OTC に基づく検査)、用途 (高脂血症、高トリグリセリド血症、家族性高コレステロール血症、低リポタンパク質血症、タンジール病、動脈硬化症など)、エンドユーザー (病院、専門クリニックと医師のオフィス、病理学研究所、診断クリニック、外来手術センター、リファレンス研究所、学術研究機関など)、流通チャネル (直接入札、小売薬局、オンライン販売など) |
|
対象国 |
米国、カナダ、メキシコ、ドイツ、フランス、英国、イタリア、スペイン、オランダ、ロシア、スイス、その他のヨーロッパ諸国、中国、日本、インド、韓国、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピン、その他のアジア太平洋諸国、ブラジル、アルゼンチン、その他の南米諸国、南アフリカ、サウジアラビア、UAE、エジプト、イスラエル、その他の中東およびアフリカ諸国 |
|
対象となる市場プレーヤー |
ヨーロッパの脂質パネル検査市場を扱っている大手企業としては、Nova Biomedical、Spark Diagnostics Pvt. Ltd.、Everlywell, Inc.、HORIBA Medical、Abbott、F. Hoffmann-La Roche Ltd.、SD Biosensor, INC.、Elitech Group、Randox Laboratories Ltd.、Diatron、Siemens Healthcare GmbH、Sinocare、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories, Inc.、myLAB Box、Awareness Technology, Inc.、Croda International Plc.、Eurofins Scientific、Boston Heart Diagnostics Corporation、cpc diagnostics、PTS Diagnostics、ARUP Laboratories、Laboratory Corporation of America Holdings、EKF Diagnostics、Beckman Coulter, Inc. (Danaher の子会社)、Sekisui Diagnostics (SEKISUI Chemical Co. Ltd. の一部門) などがあります。 |
欧州脂質パネル検査市場の定義
脂質パネルは、医療従事者が心血管疾患のリスクを監視およびスクリーニングするために使用する一般的な血液検査です。このパネルには、3 つのコレステロール測定とトリグリセリド測定が含まれます。
医療従事者は、脂質パネルを使用して、血液中のコレステロールを分析して心臓血管の健康状態を評価し、他の健康状態の診断に役立てています。脂質パネルは、血液中の脂質と呼ばれる特定の脂肪分子の存在を評価します。パネル検査として、複数の物質を測定しますが、その中にはコレステロールを含むいくつかの分子も含まれています。脂質パネルは、子供と大人の心臓病、心臓発作、脳卒中などの心臓血管疾患のリスクを評価します。
欧州脂質パネル検査市場の動向
このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。
ドライバー
- 慢性疾患の増加
脂質パネルは、医療従事者が心血管疾患やその他の慢性疾患のリスクを監視およびスクリーニングするために使用する一般的な血液検査です。パネルには、コレステロールの 3 つの測定とトリグリセリドの測定が含まれます。医療従事者や医療専門家は、主に脂質パネルをコレステロール値のスクリーニングまたはモニタリングに使用します。医療従事者は、膵炎、慢性腎臓病、甲状腺機能低下症など、脂質レベルに影響を与える可能性のある特定の健康状態の診断プロセスの一部として脂質パネルを使用することもあります。
Thus, in conclusion, the rise in the number of chronic diseases such as cardiovascular diseases, chronic kidney disorders, liver diseases, and various other chronic diseases has led to an increase in the demand for lipid profiling with increasing market demand for lipid panel testing kits will drive the growth of the Europe lipid panel testing market in coming years.
Restraint
- HIGH COST ASSOCIATED WITH TESTING PANELS
A lipid profile test is a lipid panel, cholesterol profile, or heart risk profile. This is a combination of blood tests that help measure levels of blood fats such as cholesterol and triglycerides. These cholesterol and triglycerides are good and bad types of fat.
The testing panels require a huge cost for the development process. As the concept needs to be locked down, the materials must be sourced, and it is important to consider lead times. Additionally, the process is time-consuming as the device design needs sufficient time to fully mature before entering the market.
Furthermore, any changes that must be re-verified will impact time. The growing advancements in biosensor assay formats and other complementary technologies demanded an effective investment for successful operations and a project risk management plan. Establishing R&D for conducting research entails high costs, leading to expensive devices. Thus, this factor is a major restrain for the Europe lipid panel testing market.
Opportunity
GROWTH IN TECHNOLOGICAL ADVANCEMENTS
A lipid panel is a common blood test healthcare providers use to monitor and screen for cardiovascular disease risk. The panel includes three cholesterol measurements as well as a triglyceride measurement.
Technological developments in lipid panel testing result in additional accuracy, high sensitivity, higher success rate, and newer materials, depending on their use in different lipid panel testing. The commercializing of advanced technology-based lipid panel testing devices and products used for diagnostics and testing procedures has increased consumer demand, which propels the market's demand.
Thus, the technological advancements and development of the lipid panel testing method are expected to drive growth in the Europe lipid panel testing market.
Challenge
LACK OF SKILLED & CERTIFIED PROFESSIONALS
The requirement for skilled and certified professionals is a big challenge for lipid panel testing. The demand for lipid panel testing for the diagnosis is increased due to increasing cases of obesity, cardiovascular diseases, and cholesterol Europe. However, the fewer skilled professionals in the diagnostic center are hampering the market's growth.
The instruments, methods, and procedures of lipid panel testing diagnosis have been advanced, but there are certain gaps in standardization, equalization, and knowledge. Technicians face technical training gaps related to problems and adapt advanced methods safely to perform procedures efficiently. In lipid panel testing, skilled professionals are highly needed for method development, validation, operation, and troubleshooting.
Post COVID-19 Impact Analysis on Europe Lipid Panel Testing Market
Covid-19 made a massive dent in the diagnostics sector with a steep fall in patient volumes since the beginning of 2020. The pandemic developed an eerie sense of fear among people, which eventually impacted hospital/clinic and lab visits. Regular checkups became cumbersome, stressful and time consuming. While the overall diagnostics sector seemed to have suffered a decline, the area of home diagnostics was the silver lining in the new scheme of things.
Recent Developments
- In October 2022, Eurofins Scientific, announced the commencement of the largest European biomonitoring projects for PFAS (polyfluoroalkyl) in blood Antwrep which is commissioned by the Agency for Care and Health of the Flemish Government. This product launch has helped the company in its product portfolio expansion.
- In December 2022, Laboratory Corporation of America Holdings, announced that it had begun the operations at a new, larger anatomic pathology and histology laboratory in Los Angeles. This new operations helped the company in expanding the company’s Europe central laboratory capabilities.
Europe Lipid Panel Testing Market Scope
Europe lipid panel testing market is segmented into five notable segments such as product & services, prescription mode, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
PRODUCT & SERVICES
- DEVICES
- KITS
- SERVICES
On the basis of products & services, the Europe lipid panel testing market is segmented into devices, kits and services.
PRESCRIPTION MODE
- PRESCRIPTION-BASED TESTING
- OTC-BASED TESTING
On the basis of prescription mode, the Europe lipid panel testing market is segmented into prescription-based testing and OTC-based testing.
APPLICATION
- HYPERLIPIDEMIA
- HYPERTRIGLYCERIDEMIA
- FAMILIAL HYPERCHOLESTEROLEMIA
- HYPO LIPOPROTEINAMIA
- TANGIER DISEASE
- ATHEROSCLEROSIS
- OTHERS
On the basis of application, the Europe lipid panel testing market is segmented into hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hypo lipoproteinemia, tangier disease, atherosclerosis, and others.
END USER
- HOSPITAL
- SPECIALTY CLINICS AND PHYSICIAN OFFICES
- PATHOLOGY LABORATORIES
- DIAGNOSTIC CLINICS
- AMBULATORY SURGICAL CENTERS
- REFERENCE LABORATORIES
- ACADEMIC AND RESEARCH INSTITUTES
- OTHERS
エンドユーザーに基づいて、ヨーロッパの脂質パネル検査市場は、病院、専門クリニックおよび医師のオフィス、病理学研究所、診断クリニック、外来手術センター、参照研究所、学術研究機関、その他に分類されます。
流通チャネル
- 直接入札
- 小売薬局
- オンライン販売
- その他
流通チャネルに基づいて、ヨーロッパの脂質パネル検査市場は、直接入札、小売薬局、オンライン販売、その他に分類されます。
ヨーロッパ脂質パネル検査市場の地域分析/洞察
ヨーロッパの脂質パネル検査市場は、製品とサービス、処方モード、アプリケーション、エンドユーザー、流通チャネルの 5 つの主要なセグメントに分類されます。
この市場レポートで取り上げられている国は、ドイツ、フランス、英国、イタリア、スペイン、トルコ、オランダ、ロシア、スイス、およびその他のヨーロッパ諸国です。
新興市場からの需要増加と拡大により、英国はヨーロッパ地域を支配しています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。さらに、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響が考慮されています。
競争環境と欧州脂質パネル検査市場シェア分析
ヨーロッパ脂質パネル検査市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品の承認、製品の幅と幅、アプリケーションの優位性、製品タイプのライフライン曲線が含まれます。上記のデータ ポイントは、ヨーロッパ脂質パネル検査市場への会社の重点にのみ関連しています。
ヨーロッパの脂質パネル検査市場を扱う大手企業としては、Nova Biomedical、Spark Diagnostics Pvt. Ltd.、Everlywell, Inc.、HORIBA Medical、Abbott、F. Hoffmann-La Roche Ltd.、SD Biosensor, INC.、Elitech Group、Randox Laboratories Ltd.、Diatron、Siemens Healthcare GmbH、Sinocare、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories, Inc.、myLAB Box、Awareness Technology, Inc.、Croda International Plc.、Eurofins Scientific、Boston Heart Diagnostics Corporation、cpc diagnostics、PTS Diagnostics、ARUP Laboratories、Laboratory Corporation of America Holdings、EKF Diagnostics、Beckman Coulter, Inc. (Danaher の子会社)、Sekisui Diagnostics (SEKISUI Chemical Co. Ltd. の一部門) などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE LIPID PANEL TESTING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS & SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TESTING TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 PATENT ANALYSIS
5 INDUSTRIAL INSIGHTS
5.1 KEY PRICING STRATEGY
6 EUROPE LIPID PANEL TESTING MARKET, REGULATIONS
6.1 REGULATORY SCENARIO IN EUROPE
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
7.1.2 GROWING NUMBER OF CASES OF DYSLIPIDEMIA
7.1.3 RAPID CHANGES IN LIFESTYLE CHANGES LEAD TO LIPID DISORDERS
7.1.4 RISE IN PREFERENCE FOR HOMECARE TESTING IN LIPID PANEL TESTING
7.2 RESTRAINTS
7.2.1 STRICT GOVERNMENT REGULATIONS
7.2.2 HIGH COST ASSOCIATED WITH TESTING PANELS
7.3 OPPORTUNITIES
7.3.1 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
7.3.2 RISE IN THE PREVALENCE OF OBESITY AMONG PEOPLE
7.3.3 INCREASING ADOPTION OF POINT-OF-CARE LIPID PANEL TESTING
7.4 CHALLENGES
7.4.1 LACK OF SKILLED & CERTIFIED PROFESSIONALS
7.4.2 LACK OF STANDARDIZATION OF LIPID PANEL TESTING
8 EUROPE LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES
8.1 OVERVIEW
8.2 SERVICES
8.2.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
8.2.2 TOTAL CHOLESTEROL TEST
8.2.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
8.2.4 TRIGLYCERIDES/ VLDL TEST
8.2.5 NON-HDL CHOLESTEROL TEST
8.2.6 OTHERS
8.3 KITS
8.3.1 STRIPS
8.3.1.1 THREE-ANALYTE TEST STRIPS
8.3.1.2 DUAL-ANALYTE TEST STRIPS
8.3.1.3 SINGLE-ANALYTE TEST STRIPS
8.3.2 LANCETS
8.3.3 CONTROLS
8.3.3.1 MULTI-CHEMISTRY CONTROLS
8.3.3.2 HDL CHOLESTEROL CONTROLS
8.3.3.3 OTHERS
8.3.4 CAPILLARY TUBES
8.4 DEVICES
8.4.1 BY MODALITY
8.4.1.1 STANDALONE
8.4.1.2 HANDHELD
8.4.1.3 PORTABLE
8.4.2 BY TYPE
8.4.2.1 LABORATORY BASED
8.4.2.2 POINT OF CARE BASED
9 EUROPE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE
9.1 OVERVIEW
9.2 PRESCRIPTION-BASED TESTING
9.3 OTC-BASED TESTING
10 EUROPE LIPID PANEL TESTING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 HYPERLIPIDEMIA
10.2.1 TOTAL CHOLESTEROL TEST
10.2.2 TRIGLYCERIDES/ VLDL TEST
10.2.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.2.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.2.5 NON-HDL CHOLESTEROL TEST
10.2.6 OTHERS
10.3 HYPERTRIGLYCERIDEMIA
10.3.1 TRIGLYCERIDES/ VLDL TEST
10.3.2 TOTAL CHOLESTEROL TEST
10.3.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.3.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.3.5 NON-HDL CHOLESTEROL TEST
10.3.6 OTHERS
10.4 ATHEROSCLEROSIS
10.4.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.4.2 TOTAL CHOLESTEROL TEST
10.4.3 TRIGLYCERIDES/ VLDL TEST
10.4.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.4.5 NON-HDL CHOLESTEROL TEST
10.4.6 OTHERS
10.5 FAMILIAL HYPERCHOLESTEROLEMIA
10.5.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.5.2 TOTAL CHOLESTEROL TEST
10.5.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.5.4 TRIGLYCERIDES/ VLDL TEST
10.5.5 NON-HDL CHOLESTEROL TEST
10.5.6 OTHERS
10.6 HYPO LIPOPROTEINEMIA
10.6.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.6.2 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.6.3 TRIGLYCERIDES/ VLDL TEST
10.6.4 TOTAL CHOLESTEROL TEST
10.6.5 NON-HDL CHOLESTEROL TEST
10.6.6 OTHERS
10.7 TANGIER DISEASE
10.7.1 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.7.2 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.7.3 TOTAL CHOLESTEROL TEST
10.7.4 TRIGLYCERIDES/ VLDL TEST
10.7.5 NON-HDL CHOLESTEROL TEST
10.7.6 OTHERS
10.8 OTHERS
11 EUROPE LIPID PANEL TESTING MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.2.1 BY TYPE
11.2.1.1 PRIVATE
11.2.1.1.1 SERVICES
11.2.1.1.2 KITS
11.2.1.1.3 DEVICES
11.2.1.2 PUBLIC
11.2.1.2.1 SERVICES
11.2.1.2.2 KITS
11.2.1.2.3 DEVICES
11.2.2 BY TIER
11.2.2.1 TIER 1
11.2.2.1.1 SERVICES
11.2.2.1.2 KITS
11.2.2.1.3 DEVICES
11.2.2.2 TIER 2
11.2.2.2.1 SERVICES
11.2.2.2.2 KITS
11.2.2.2.3 DEVICES
11.2.2.3 TIER 3
11.2.2.3.1 SERVICES
11.2.2.3.2 KITS
11.2.2.3.3 DEVICES
11.3 DIAGNOSTIC CLINICS
11.3.1 SERVICES
11.3.2 KITS
11.3.3 DEVICES
11.4 SPECIALTY CLINICS & PHYSICIAN OFFICES
11.4.1 SERVICES
11.4.2 KITS
11.4.3 DEVICES
11.5 REFERENCE LABORATORIES
11.5.1 SERVICES
11.5.2 KITS
11.5.3 DEVICES
11.6 AMBULATORY SURGICAL CENTERS
11.6.1 SERVICES
11.6.2 KITS
11.6.3 DEVICES
11.7 PATHOLOGY LABORATORIES
11.7.1 SERVICES
11.7.2 KITS
11.7.3 DEVICES
11.8 ACADEMIC AND RESEARCH INSTITUTES
11.8.1 SERVICES
11.8.2 KITS
11.8.3 DEVICES
11.9 OTHERS
12 EUROPE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL PHARMACY
12.3.1 HOSPITAL PHARMACIES
12.3.2 DRUG STORES
12.3.3 OTHERS
12.4 ONLINE SALES
12.5 OTHERS
13 EUROPE LIPID PANEL TESTING MARKET, BY REGION
13.1 EUROPE
13.1.1 U.K.
13.1.2 GERMANY
13.1.3 FRANCE
13.1.4 RUSSIA
13.1.5 ITALY
13.1.6 SPAIN
13.1.7 TURKEY
13.1.8 NETHERLANDS
13.1.9 SWITZERLAND
13.1.10 REST OF EUROPE
14 EUROPE LIPID PANEL TESTING MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 EUROPE LIPID PANEL TESTING MARKET, COMPANY PROFILE
16.1 QUEST DIAGNOSTICS INCORPORATED
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 EUROFINS SCIENTIFIC
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 F. HOFFMANN-LA ROCHE LTD.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 RANDOX LABORATORIES LTD.
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ABBOTT
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 COMPANY SHARE ANALYSIS
16.6.4 PRODUCT PORTFOLIO
16.6.5 RECENT DEVELOPMENT
16.7 AWARENESS TECHNOLOGY, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ARUP LABORATORIES
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BIO-RAD LABORATORIES, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER)
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 BOSTON HEART DIAGNOSTICS CORPORATION
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 CPC DIAGNOSTICS
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 CRODA INTERNATIONAL PLC.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 DIATRON
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 EKF DIAGNOSTICS
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 EVERLYWELL, INC.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 ELITECH GROUP
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 HORIBA MEDICAL
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 MYLAB BOX
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 NOVA BIOMEDICAL
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 PTS DIAGNOSTICS
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 SIEMENS HEALTHCARE GMBH
16.22.1 COMPANY SNAPSHOT
16.22.2 REVENUE ANALYSIS
16.22.3 PRODUCT PORTFOLIO
16.22.4 RECENT DEVELOPMENT
16.23 SINOCARE
16.23.1 COMPANY SNAPSHOT
16.23.2 REVENUE ANALYSIS
16.23.3 PRODUCT PORTFOLIO
16.23.4 RECENT DEVELOPMENT
16.24 SD BIOSENSOR, INC.
16.24.1 COMPANY SNAPSHOT
16.24.2 REVENUE ANALYSIS
16.24.3 PRODUCT PORTFOLIO
16.24.4 RECENT DEVELOPMENT
16.25 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.)
16.25.1 COMPANY SNAPSHOT
16.25.2 REVENUE ANALYSIS
16.25.3 PRODUCT PORTFOLIO
16.25.4 RECENT DEVELOPMENTS
16.26 SPARK DIAGNOSTICS PVT. LTD.
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
16.27 THERMO FISHER SCIENTIFIC INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 REVENUE ANALYSIS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
表のリスト
TABLE 1 THE BELOW-MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID PANEL TESTING DEVICES OFFERED BY DIFFERENT MANUFACTURERS-
TABLE 2 EUROPE LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES, 2021-2030 (USD MILLION)
TABLE 3 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 5 EUROPE KITS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 EUROPE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 EUROPE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 9 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 11 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 EUROPE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 13 EUROPE PRESCRIPTION-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE OTC-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 EUROPE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 EUROPE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 EUROPE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 EUROPE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 EUROPE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 EUROPE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 24 EUROPE HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 EUROPE HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 EUROPE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 EUROPE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 30 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 EUROPE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 33 EUROPE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 35 EUROPE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 36 EUROPE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 EUROPE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 38 EUROPE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 EUROPE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 EUROPE SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 EUROPE SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 EUROPE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 EUROPE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 44 EUROPE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 EUROPE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 EUROPE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 EUROPE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 48 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 50 EUROPE OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 EUROPE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 52 EUROPE DIRECT TENDER IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 EUROPE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 EUROPE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 55 EUROPE ONLINE SALES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 EUROPE OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 EUROPE LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 59 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 60 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 61 EUROPE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 EUROPE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 EUROPE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 65 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 66 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 67 EUROPE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 68 EUROPE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 EUROPE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 EUROPE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 EUROPE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 EUROPE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 EUROPE HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 EUROPE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 EUROPE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 76 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 EUROPE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 EUROPE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 80 EUROPE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 81 EUROPE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 82 EUROPE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 83 EUROPE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 84 EUROPE SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 85 EUROPE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 86 EUROPE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 87 EUROPE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 88 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 EUROPE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 90 EUROPE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 91 U.K. LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 92 U.K. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 93 U.K. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 94 U.K. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 95 U.K. KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 U.K. STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 U.K. CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 99 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 101 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 102 U.K. LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 103 U.K. LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 U.K. HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 U.K. HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 106 U.K. ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 U.K. FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 U.K. HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 109 U.K. TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 110 U.K. LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 U.K. HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 112 U.K. PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 113 U.K. PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 U.K. HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 115 U.K. TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 116 U.K. TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 U.K. TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 U.K. DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 119 U.K. SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 U.K. REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 U.K. AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 122 U.K. PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 123 U.K. ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 124 U.K. LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 125 U.K. RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 126 GERMANY LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 127 GERMANY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 128 GERMANY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 129 GERMANY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 130 GERMANY KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 131 GERMANY STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 132 GERMANY CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 134 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 135 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 136 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 137 GERMANY LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 138 GERMANY LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 GERMANY HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 140 GERMANY HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 GERMANY ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 GERMANY FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 GERMANY HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 144 GERMANY TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 145 GERMANY LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 146 GERMANY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 147 GERMANY PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 GERMANY PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 GERMANY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 150 GERMANY TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 GERMANY TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 152 GERMANY TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 153 GERMANY DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 154 GERMANY SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 155 GERMANY REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 156 GERMANY AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 GERMANY PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 GERMANY ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 GERMANY LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 GERMANY RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 161 FRANCE LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 162 FRANCE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 163 FRANCE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 164 FRANCE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 165 FRANCE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 166 FRANCE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 167 FRANCE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 168 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 169 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 170 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 171 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 172 FRANCE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 173 FRANCE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 FRANCE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 FRANCE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 FRANCE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 FRANCE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 178 FRANCE HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 FRANCE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 180 FRANCE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 181 FRANCE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 182 FRANCE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 183 FRANCE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 FRANCE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 185 FRANCE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 186 FRANCE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 187 FRANCE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 188 FRANCE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 189 FRANCE SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 190 FRANCE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 191 FRANCE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 192 FRANCE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 193 FRANCE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 194 FRANCE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 195 FRANCE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 196 RUSSIA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 197 RUSSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 198 RUSSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 199 RUSSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 200 RUSSIA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 201 RUSSIA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 202 RUSSIA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 203 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 204 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 205 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 206 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 207 RUSSIA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 208 RUSSIA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 209 RUSSIA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 210 RUSSIA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 211 RUSSIA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 212 RUSSIA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 213 RUSSIA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 214 RUSSIA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 RUSSIA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 RUSSIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 217 RUSSIA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 218 RUSSIA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 219 RUSSIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 220 RUSSIA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 221 RUSSIA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 222 RUSSIA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 223 RUSSIA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 224 RUSSIA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 225 RUSSIA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 226 RUSSIA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 227 RUSSIA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 228 RUSSIA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 229 RUSSIA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 230 RUSSIA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 231 ITALY LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 232 ITALY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 233 ITALY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 234 ITALY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 235 ITALY KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 236 ITALY STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 237 ITALY CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 238 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 239 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 240 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 241 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 242 ITALY LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 243 ITALY LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 ITALY HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 245 ITALY HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 ITALY ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 ITALY FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 ITALY HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 ITALY TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 ITALY LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 251 ITALY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 252 ITALY PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 253 ITALY PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 254 ITALY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 255 ITALY TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 256 ITALY TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 257 ITALY TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 258 ITALY DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 ITALY SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 260 ITALY REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 ITALY AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 262 ITALY PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 263 ITALY ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 264 ITALY LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 265 ITALY RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 266 SPAIN LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 267 SPAIN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 268 SPAIN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 269 SPAIN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 270 SPAIN KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 271 SPAIN STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 272 SPAIN CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 273 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 274 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 275 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 276 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 277 SPAIN LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 278 SPAIN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 279 SPAIN HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 280 SPAIN HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 281 SPAIN ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 282 SPAIN FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 283 SPAIN HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 284 SPAIN TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 285 SPAIN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 286 SPAIN HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 SPAIN PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 288 SPAIN PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 289 SPAIN HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 290 SPAIN TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 291 SPAIN TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 292 SPAIN TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 293 SPAIN DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 294 SPAIN SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 295 SPAIN REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 296 SPAIN AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 297 SPAIN PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 298 SPAIN ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 299 SPAIN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 300 SPAIN RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 301 TURKEY LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 302 TURKEY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 303 TURKEY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 304 TURKEY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 305 TURKEY KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 306 TURKEY STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 307 TURKEY CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 308 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 309 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 310 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 311 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 312 TURKEY LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 313 TURKEY LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 314 TURKEY HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 315 TURKEY HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 316 TURKEY ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 317 TURKEY FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 318 TURKEY HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 319 TURKEY TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 320 TURKEY LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 321 TURKEY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 322 TURKEY PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 323 TURKEY PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 324 TURKEY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 325 TURKEY TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 326 TURKEY TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 327 TURKEY TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 328 TURKEY DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 329 TURKEY SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 330 TURKEY REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 331 TURKEY AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 332 TURKEY PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 333 TURKEY ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 334 TURKEY LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 335 TURKEY RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 336 NETHERLANDS LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 337 NETHERLANDS SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 338 NETHERLANDS SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 339 NETHERLANDS SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 340 NETHERLANDS KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 341 NETHERLANDS STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 342 NETHERLANDS CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 343 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 344 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 345 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 346 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 347 NETHERLANDS LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 348 NETHERLANDS LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 349 NETHERLANDS HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 350 NETHERLANDS HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 351 NETHERLANDS ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 352 NETHERLANDS FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 353 NETHERLANDS HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 NETHERLANDS TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 355 NETHERLANDS LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 356 NETHERLANDS HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 357 NETHERLANDS PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 358 NETHERLANDS PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 359 NETHERLANDS HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 360 NETHERLANDS TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 361 NETHERLANDS TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 362 NETHERLANDS TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 363 NETHERLANDS DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 364 NETHERLANDS SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 365 NETHERLANDS REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 366 NETHERLANDS AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 367 NETHERLANDS PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 368 NETHERLANDS ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 369 NETHERLANDS LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 370 NETHERLANDS RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 371 SWITZERLAND LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 372 SWITZERLAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 373 SWITZERLAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 374 SWITZERLAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 375 SWITZERLAND KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 376 SWITZERLAND STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 377 SWITZERLAND CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 378 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 379 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 380 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 381 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 382 SWITZERLAND LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 383 SWITZERLAND LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 384 SWITZERLAND HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 385 SWITZERLAND HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 386 SWITZERLAND ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 387 SWITZERLAND FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 388 SWITZERLAND HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 389 SWITZERLAND TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 390 SWITZERLAND LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 391 SWITZERLAND HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 392 SWITZERLAND PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 393 SWITZERLAND PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 394 SWITZERLAND HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 395 SWITZERLAND TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 396 SWITZERLAND TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 397 SWITZERLAND TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 398 SWITZERLAND DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 399 SWITZERLAND SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 400 SWITZERLAND REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 401 SWITZERLAND AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 402 SWITZERLAND PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 403 SWITZERLAND ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 404 SWITZERLAND LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 405 SWITZERLAND RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 406 REST OF EUROPE LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
図表一覧
FIGURE 1 EUROPE LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 2 EUROPE LIPID PANEL TESTING MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE LIPID PANEL TESTING MARKET: DROC ANALYSIS
FIGURE 4 EUROPE LIPID PANEL TESTING MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE LIPID PANEL TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE LIPID PANEL TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE LIPID PANEL TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE LIPID PANEL TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 EUROPE LIPID PANEL TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE EUROPE LIPID PANEL TESTING MARKET IN THE FORECAST PERIOD
FIGURE 12 THE PRODUCTS & SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE LIPID PANEL TESTING MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE LIPID PANEL TESTING MARKET
FIGURE 14 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2022
FIGURE 15 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, CAGR (2023-2030)
FIGURE 17 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, LIFELINE CURVE
FIGURE 18 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2022
FIGURE 19 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, CAGR (2023-2030)
FIGURE 21 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, LIFELINE CURVE
FIGURE 22 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, 2022
FIGURE 23 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE LIPID PANEL TESTING MARKET: BY END USER, 2022
FIGURE 27 EUROPE LIPID PANEL TESTING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE LIPID PANEL TESTING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE LIPID PANEL TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE LIPID PANEL TESTING MARKET: SNAPSHOT (2022)
FIGURE 35 EUROPE LIPID PANEL TESTING MARKET: BY COUNTRY (2022)
FIGURE 36 EUROPE LIPID PANEL TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 EUROPE LIPID PANEL TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 EUROPE LIPID PANEL TESTING MARKET: PRODUCTS & SERVICES (2023-2030)
FIGURE 39 EUROPE LIPID PANEL TESTING MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
